MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

计划入组 38 人 · 首次发布于 2022 年 3 月 18 日

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

计划入组 38 人 · 首次发布于 2022 年 2 月 10 日

Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria

计划入组 400 人 · 首次发布于 2019 年 8 月 1 日

Adamantanone

C₁₀H₁₄O

Adamantane

C₁₀H₁₆

Lacosamide controlled release (Adamas Pharmaceuticals)

Adamas Pharmaceuticals, Inc.

United States

Adamas Pharma, LLC

United States

ADAM OLSON

United States

ADAMA and BASF Partner to Commercialize Novel Fungicide Gilboa for European Cereal Disease Management

First Synthetic Cell Built From Scratch Achieves Growth, DNA Replication, and Division

Parabilis Medicines Achieves First-Ever Clinical Success Targeting "Undruggable" β-Catenin:TCF Interaction with FOG-001